Navigation Links
Warfarin’s Anti-clotting Property May Cause Hemorrhagic Stroke

Warfarin, an anti-clotting drug given to patients suffering from atrial fibrillation has proved effective //by reducing the number of strokes due to clotting.

However, its anti-clotting property has led to an increase in the number of strokes caused by bleeding to the brain particularly in patients over the age of 80, according to a new study.

Warfarin was earlier used as rat poison, after research in the nineties suggested Warfarin reduced the risk of ischemic stroke it became a standard treatment for people suffering from atrial fibrillation.

Matthew Flaherty, the lead researcher and a neurologist at the University of Cincinnati in Ohio, said the study results don’t necessarily mean that use of warfarin should be given up, but motivate physicians to make sure that the drug is being used appropriately.

"Doctors can use these findings to make sure they are weighing the risks and benefits of warfarin use for their patients," he said.

“The benefits of anti-clotting drugs are "undeniable" for some patients, such as those who have had blood clots,” Dr. Flaherty said.

The researcher said more research was needed to find anti-coagulants safer than warfarin to help patients who suffer from hemorrhagic strokes.

All cases of intracerebral hemorrhage (bleeding inside the brain) in the Cincinnati area between 1988 and 1999 were examined by the study. The cases connected with the use of blood-thinning drugs soared to 4.4 cases per 100,000 people by 1999 from 0.8 cases per 100,000 in 1988. In comparison, the rate of hemorrhagic strokes associated to warfarin use, rose to 45.9 per 100,000 in 1999 from 2.5 per 100,000 in 1988.

The study notes that, between 1993 and 1999, the rate of ischemic stroke in patients suffering from atrial fibrillation remained fixed at about 22 per 100,000. But previous research has shown that warfarin use has halved the rate of ischemic stroke in pat ients with atrial fibrillation.

Warfarin is known by its brand name Coumadin, which is a product of Bristol Myers Squibb.

Warfarin is used to prevent clotting in the deep-seated veins of the lower leg (deep vein thrombosis), and also to prevent pulmonary embolism in patients having chronic obstructive pulmonary disorder (COPD).


Related medicine news :

1. Aspirin surpasses Modern Anti-clotting Drugs
2. Fruits And Vegetables Have Arthritis Risk Reducing Property
3. Cancer-causing Property Of Teflon Leaves US Regulators Concerned
4. Opposition against Amendments in the Intellectual Property Law
5. Is Diabetes the Leading Cause of Kidney Failure in India
6. Antibiotics Dangerous for Diarrhoea in Children Caused by E.Coli
7. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
8. Breast Cancer Surgery Causes Psychological problems
9. Arthritis Drug May Cause Liver Damage
10. Causes of weakness in the aged
11. Gene Mutation Causes Ovarian Failure
Post Your Comments:

(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's ... President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. ... 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming the role ...
(Date:10/13/2017)... , ... October 13, 2017 , ... PurhealthRX , ... Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize ... providing a CBD form that can be easily incorporated into liquid products, while reducing ...
(Date:10/13/2017)... QUEENS, N.Y (PRWEB) , ... October 13, 2017 , ... ... recently became a member of ElderCounsel, a national organization of elder law and special ... constantly changing laws and rules. It also provides a forum to network with elder ...
(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
(Date:10/13/2017)... ... 13, 2017 , ... Ellevate Network, the leading network for professional women, brought ... gender equality at their inaugural Summit in New York City in June. The event ... audience of over 3 million. To watch the Mobilize Women video, click here ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017 West ... in innovative solutions for injectable drug administration, today announced ... the market opens on Thursday, October 26, 2017, and ... results and business expectations at 9:00 a.m. Eastern Time. ... or 253-336-8738 (International). The conference ID is 94093362. ...
(Date:10/11/2017)... , Oct. 11, 2017  Hill-Rom Holdings, Inc. ... Aspen Surgical facility in Las Piedras, Puerto ... scalpels and blades. ... that the facility sustained minor structural damage, temporary loss ... Maria. Repairs have been completed, manufacturing operations have resumed, ...
(Date:10/5/2017)... 2017  In response to the nationwide opioid ... Surgeons (AAOMS) released prescribing recommendations that urge ibuprofen ... as a first-line therapy to manage a patient,s ... Recognizing the value and importance of ... Prescribing: Acute and Postoperative Pain Management" stresses that ...
Breaking Medicine Technology: